Independent Online

Tuesday, August 9, 2022

Like us on FacebookFollow us on TwitterView weather by locationView market indicators

The global race to find Covid-19 vaccine

A new clinical trial investigating whether the measles, mumps and rubella (MMR) vaccine can protect health care workers from being infected with Covid-19, is expected to be launched in South Africa.

A new clinical trial investigating whether the measles, mumps and rubella (MMR) vaccine can protect health care workers from being infected with Covid-19, is expected to be launched in South Africa.

Published Jul 16, 2020

Share

DURBAN - United States biotech firm Moderna is in a leading position in the global race to find a vaccine against the coronavirus, which has infected more than 13.2 million people and killed 570,000.

The company announced Tuesday that it would enter the final stage of human trials for its Covid-19 vaccine on July 27, after promising early results were published in a medical journal.

Story continues below Advertisement

China’s Sinovac Biotech is expected to begin Phase 3 trials of Coronavirus Vaccine Candidate in Brazil. The Brazilian national regulatory agency, Anvisa, granted approval to a phase 3 clinical trial to test efficacy and safety of the inactivated Covid-19 vaccine.

Meanwhile, Russian researchers

announced

Share